<DOC>
	<DOCNO>NCT00152685</DOCNO>
	<brief_summary>Experimentally high dose hyperoncotic human serum albumin improve neurological recovery head injury reduce cerebral edema normalize apparent diffusion coefficient water ischemia reperfusion . The main hypothesis early administration hyperoncotic serum albumin able reduce intracranial pressure several day severe head injury thus reduce mortality morbidity .</brief_summary>
	<brief_title>High Dose Hyperoncotic Serum Albumin Treatment Acute Phase Severe Head Injury</brief_title>
	<detailed_description />
	<mesh_term>Craniocerebral Trauma</mesh_term>
	<criteria>severe head injury ( GCS &lt; 9 ) Next kin inform consent Cranio cerebral wound Pregnancy Hypoxemia ( PaO2/FiO2 &lt; 300 mmHg ) Blood loss &gt; 1/2 blood mass Renal cardiac failure , uncontrolled hypertension Head injury date 24 hour time inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>